tiprankstipranks
Trending News
More News >
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market

Fulcrum Therapeutics (FULC) Income Statement

Compare
520 Followers

Fulcrum Therapeutics Income Statement

Last quarter (Q4 2025), Fulcrum Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Fulcrum Therapeutics's net income was $-20.33M. See Fulcrum Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 80.00M$ 2.81M$ 6.34M$ 19.16M
Gross Profit
$ -1.39M$ 78.41M$ 2.81M$ -70.44M$ -50.54M
Operating Expenses
$ 83.38M$ 38.51M$ 113.47M$ 42.12M$ 30.52M
Depreciation and Amortization
$ 1.39M$ 1.59M$ 2.17M$ 2.41M$ 2.52M
EBITDA
$ -73.49M$ -18.24M$ -108.49M$ -109.72M$ -78.54M
Operating Income
$ -84.77M$ -21.90M$ -110.66M$ -112.56M$ -81.05M
Other Income/Expenses
$ 9.89M$ 12.17M$ 13.33M$ 2.69M$ 207.00K
Pretax Income
$ -74.88M$ -9.72M$ -97.33M$ -109.87M$ -80.85M
Net Income
$ -74.88M$ -9.72M$ -97.33M$ -109.87M$ -80.85M
Per Share Metrics
Basic EPS
$ -1.18$ -0.16$ -1.59$ -2.35$ -2.22
Diluted EPS
$ -1.18$ -0.16$ -1.59$ -2.35$ -2.22
Weighted Average Shares Outstanding
63.35M 61.98M 61.31M 44.99M 35.36M
Weighted Average Shares Outstanding (Diluted)
63.35M 61.98M 61.31M 44.99M 35.36M
Currency in USD

Fulcrum Therapeutics Earnings and Revenue History